Precision Health Ecosystem
BlueFairy is a high-fidelity data lake and customizable data solution — built with our community to improve outcomes for complex chronic conditions.
We share health data responsibly. BlueFairy is designed for HIPAA-aligned care.
Americans are affected by autoimmunity, with incidence growing at 12% year over year — far outpacing population growth.
Spent annually, with comorbidities that overlap cancer, cardiovascular disease, and fertility.
Out-of-pocket spending for complementary testing and self-directed research. Patients are sharing sensitive data in non-HIPAA forums.
BlueFairy is a high-fidelity data lake and customizable data solution. We integrate multiple health APIs and unique patient cohort sets, provide personalized insights, and fuel clinical breakthroughs.
A secure, interoperable foundation for patient-reported data, health APIs, wearable signals, and future testing integrations.
Personalized insights that connect people, clinicians, and researchers across complex chronic conditions.
Our value is better outcomes — and the future of precision health built on data that serves patients first.
Precision health is compounding. We don't pick winners — the data determines what best serves customers.
20% CAGR to $34B, fueled by expanding health records and precision health tools.
12.8% CAGR, $20B — continuous signals that make care more explorable and actionable.
16.7% CAGR. $49B today, an estimated $232B by 2034 — a once-in-a-generation market shift.
Focus on a half-dozen conditions where we overlap treatment protocols for new phenotyping.
Collate patient and pet data to accelerate treatment interventions.
Explorable wearable and hardware integrations that help serve clinicians under device categories.
Our team has direct experience with autoimmune conditions — and the engineering, clinical, and data science depth to build this carefully.
Engineer turned digital-health founder after being diagnosed with the same autoimmune disorder as her cat. Emmy-nominated, Forbes Next 1000 awardee, and serial entrepreneur who has bootstrapped two companies.
Electronics and AI engineer focused on privacy-preserving, interoperable systems. His wife has managed several autoimmune conditions for over half her life — a personal commitment to patient-centered design.
Statistician spanning bioinformatics, clinical drug development, and AI. Yale adjunct, ex-Genentech Senior Principal Scientist, Head of Data Science at N-Power Medicine, and Head of Early Development Biostatistics at Exelixis.
CUNY valedictorian with a Nutrition Science degree. Early hire focused on functional, food-as-medicine approaches and patient-centric strategy.
Hospitalist at Weil Cornell and CMO at Critica, focused on medical misinformation and social determinants of health.
Molecular geneticist advising on genomics and precision medicine.
Program Director at the National Science Foundation and leader of the 90-10 Institute, a biotech industry think tank based in Berkeley.
Presidential Institute Fellow and Knight Foundation Awardee.
JP Morgan Chase VP Innovation Economy; former TechStars NYC Alumni Lead and founding member of Digital Health of NY.
Additional advisory guidance from prior organizations and domain experts.
Waitlist of several hundred patients. Functional MVP accepting FSA/HSA payments. Commitments to sponsor 100+ seats for low-income patients.
DNA test to optimize medications per patient, clinical trials and startup collaborations, and discussions with LabCorp for testing infrastructure.
Grant recipient chosen over 40,000 applicants; accepted into Google's Patent Project with pro-bono representation by Sterne Kessler; NVIDIA Startup Inception Program; invited to apply to NSF Seed Fund (Phase 1 $250K, Phase 2 $1M+); employee grant ~$30K.
BlueFairy connects health-data work to measurable, real-world impact. Our name comes from the BlueFairy — who encourages Pinocchio to avoid risky behavior and eventually fulfills his greatest desire: becoming real.